Radiculopathy near Cliffside Park, NJ

Biography: Robert J. Sommer, MD, is an accomplished medical professional and Associate Professor of Medicine at Columbia University Irving Medical Center. He currently serves as the Director of Invasive Adult Congenital Heart Disease at Columbia's Interventional Cardiovascular Care program, based in Columbia University Irving Medical Center/NewYork-Presbyterian.Dr. Sommer's expertise lies in the areas of pediatric cardiology, adult congenital heart disease, and interventional cardiology. He is Board-certified in both Pediatric and Adult Congenital Heart Disease. He completed his training in pediatrics and pediatric cardiology at Mount Sinai Hospital in New York City and Boston Children's Hospital in Boston. CLINICAL WORKIn 1991, Dr. Sommer made significant contributions to the field by establishing the first comprehensive pediatric interventional catheterization laboratory in New York City. In 1999, he launched his own practice and redirected his focus towards the growing population of adult patients with congenital heart disease. Dr. Sommer's joined the faculty at Columbia University Irving Medical Center in 2005.Dr. Sommer has expertise in a diverse range of congenital and structural heart interventions. Dr. Sommer directs the Left Atrial Appendage Closure Team at Columbia, having participated in the PREVAIL Trial, the CAP2 registry, and the CHAMPION-AF Trials using the Watchman Device, as well as the Amulet Device Pivotal and Conformal Device Feasibility Trial. In addition to diagnostic catheterizations in complex congenital heart disease, he performs over 200 atrial septal defect and patent foramen ovale (PFO) closures and over 100 left atrial appendage closures annually. He has decades of experience in closing patent ductus arteriosus and ventricular septal defects, as well as, stenting coarctation of the aorta. Currently, Dr. Sommer serves as the national cardiology principal investigator for the GORE RELIEF clinical study to evaluate patent foramen ovale (PFO) closure for migraine headache relief using a device called the GORE CARDIOFORM Septal Occlude.Dr. Sommer collaborates closely with his Pediatric Cardiology colleagues at Columbia performing transcatheter pulmonary valve replacements in the congenital population. Together, with Barbara Robbins, NP, he provides primary cardiac care to a population of more than 300 pediatric and adult patients with congenital heart disease. Jointly, they manage more than 1500 office visits annually.

Biography: Dr. Hasan Garan, MD is a Cardiology Specialist who practices in New York, NY. He is 79 years old and has been practicing for 51 years. Dr. Hasan Garan, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Sinha specializes in metabolic bone diseases including osteoporosis and parathyroid disorders. She also specializes in obesity and the effects bariatric surgery on the endocrine system. She is a member of the islet transplantation team and is interested in the care of post-transplant diabetes.

Biography: Dr. Evelyn Horn is the Director of the Perkin Heart Failure Center of Weill Cornell, specializing in Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support.Patients referred to the Center include those with diagnoses of systolic heart failure, valvular heart disease, preserved EF heart failure; pulmonary vascular disease - idiopathic, associated and secondary.Evelyn M. Horn, M.D. is a graduate of Brown University, Mount Sinai Medical School where she also was a medical intern and resident. She completed cardiology at the Cedars Sinai/UCLA program and thereafter spent 2 years as a research fellow at Columbia College of Physicians and Surgeons understanding the beta adrenergic G protein complex in heart failure, the denervated heart and models of arrhythmias. She remained at Columbia University Medical Center in the Divisions of Circulatory Physiology and Cardiology Center for Advanced Cardiac Care where she was at various times, Director of the Circulatory Physiology fellowship program, Director of Clinical Services for Heart Failure, Associate Director of the combined Pediatric & Adult Pulmonary Hypertension Center and Director of the Pulmonary Vascular program of the Center for Advanced Cardiac Care. She also was the director of the High Risk Cardiac Obstetrical program. She received numerous awards as clinician educator, continues to participate in clinical research in the areas of cardiac and vascular remodeling in heart failure and pulmonary hypertension.The Heart Failure program provides management of advanced heart failure (both systolic and diastolic), congenital heart disease, perioperative management of conventional cardiac surgical patients (high risk patients and high risk valve surgery), and ventricular assist devices. The center also offers rare expertise in the management of pulmonary hypertension, including idiopathic pulmonary hypertension and pulmonary hypertension associated with diseases such as connective tissue disease, congenital heart disease as well as a huge number of patients who have it in association with left heart disease and others have it associated with lung disease, certain hematological diseases or liver disease. Pulmonary hypertension and right heart failure complicates the management of about 1/3 of the patients with heart failure. In many, right heart failure follows left heart failure but management of difficult "cases" may require a special expertise and understanding of the interdependence of the right and the left ventricles. If cases become complicated by secondary pulmonary hypertension or right heart failure, most of Dr. Horn's colleagues seek out the "right heart doctor," as she has sometimes been called or the combined left and right heart doc.The phenotype of heart failure has multiple etiologies, and not all heart failure behaves the same way. Because of the nuances and subtleties involved in advanced heart failure, she stresses the importance of the multidisciplinary, collaborative center. Moreover, Dr. Horn points to the center's expertise in identifying the appropriateness and the optimal timing of therapeutic interventions. "We have fantastic technologies and therapies available, but these may not be in every patient's best interest," she explains. "It is essential to understand when therapies will or will not work, and when one has to move beyond them, perhaps to mechanical assist devices or heart transplantation for heart failure and lung transplantation for pulmonary hypertension. If we wait too long, we may have missed the opportunity to treat a patient, but no one wants to resort to devices or transplantation before a patient absolutely needs it."Dr. Horn's clinical research interests have been in ventricular and vascular remodeling in pulmonary hypertension and heart failure. Specific areas have included RV imaging, pulmonary hypertension outcome studies, use of vasopressin in pulmonary hypertension, endothelial dysfunction in pulmonary hypertension, RV dysfunction in the perioperative patient population, complications of pulmonary hypertension therapy, and assessment of the non PAH pulmonary hypertension patient population. She has been actively involved in the care of patients with valvular heart disease and in particular comorbidities of ventricular dysfunction and/or pulmonary vascular disease. She has been actively involved in the care of patients needing ventricular assist device therapies as a bridging or destination device. Along with colleagues, she has authored papers in the field of newer therapies for pulmonary hypertension, epidemiological assessments of patients with pulmonary hypertension, genetics of pulmonary hypertension, and markers of vascular dysfunction. She has been involved in industry sponsored heart failure and pulmonary hypertension studies, industry sponsored investigator initiated studies and collaborative NIH studies in Heart Failure and Pulmonary Hypertension. She has also been the liaison to high risk cardiac OB programs for the care of the complicated cardiac OB patient.Research and invited lectures have been presented at major National and International meetings. She is a fellow of the International Pulmonary Vascular Research Institute, helping to establish ISLHT Pulmonary Hypertension Committee and has been the recipient of teaching awards at Columbia University. Dr. Horn has created a NY Pulmonary Hypertension consortium, a network of a dozen specialists from the tri-state area, to encourage ongoing collaborative studies in pulmonary hypertension.

Care Philosophy: Dr. Sharaiha is dedicated to putting her patients first. She has a special interest in the endoscopic treatment of obesity and the diseases of the pancreas and biliary tract, including pancreatitis, fluid collection, sphincter of oddi dysfunction and pancreatic cancer. She is grant funded for trials with malignant biliary obstruction. She sees patients for advanced endoscopic procedures, staging of GI cancers, and treatment or removal of early cancer lesions, surveillance and ablation of pancreatic cysts, and for obesity treatment.

Biography: Dr. David Wan is an Assistant Professor of Medicine and Attending Physician at the New York Presbyterian-Weill Cornell Medical Center in The Division of Gastroenterology and Hepatology.Dr. Wan earned his Bachelor of Science in Neuroscience at Brown University prior to getting his medical degree at NYU where he graduated Alpha Omega Alpha. He completed his residency in Internal Medicine at New York Presbyterian-Weill Cornell Medical Center and his Gastroenterology fellowship at NYU.Dr. Wan has a wide variety of interests within gastroenterology and hepatology. One of his main roles will be in the training of gastroenterology fellows in endoscopy/colonoscopy and the inpatient consultation service. He is a member of the American College of Gastroenterology and the American and New York Societies of Gastrointestinal Endoscopy.

Biography: Recruited to Cornell in 1999, Dr. Segal was responsible for the founding and development of the New York Presbyterian Hospital/Weill Cornell Stroke program and supervised NYPs designation as a New York State Primary Stroke Center. This program includes aggressive management of acute stroke, using both intravenous rtPA and intra-arterial therapies such as thrombolysis, and mechanical clot extraction. Dr. Segal's research interests include the relationship between Stroke and Cancer, through which he has collaborated extensively with the Memorial Sloan Kettering Cancer Center. Dr. Segal has been the co-course director of the NYP Brain Attack Course which attracts 400 attendees yearly. Inpatient and outpatient clinical consultations address a wide range of issues relating to cerebrovascular disease. Dr. Segal also accepts referrals for general outpatient neurology.In 2010, Dr. Segal expanded his practice into Sleep Disorders and is currently active in the newly expanded and renovated Weill Cornell Sleep Disorders Center. Dr. Segal's sleep practice includes the full spectrum of Sleep Disorders, including but not limited to Sleep Apnea and Sleep Disordered Breathing, Insomnia/Hypersomnia, Narcolepsy, and Restless Legs Syndrome. Dr. Segal offers collaborations with psychologists and pulmonologists in the Sleep Disorders Center to offer a full multi-disciplinary approach to patient care.Dr. Segal received his bachelor's degree from Harvard College and MD degree from Columbia College of Physicians and Surgeons. He received postgraduate training at the Massachusetts General Hospital where he completed residencies in Internal Medicine and Neurology, followed by fellowship in Stroke and Neurocritical Care. He is Associate Professor of Clinical Neurology and Director of the Neurology Residency Training Program and Vascular Neurology Fellowship. Dr. Segal has published widely in the fields of Stroke, Sleep Medicine and General Neurology.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.